Fort Worth location page of R3 Stem Cell, a commercial regenerative medicine network offering stem cell, exosome and platelet injections for joint, neurological and autoimmune conditions.
R3 Stem Cell Fort Worth is a location page within a commercial regenerative medicine network that says it operates more than 80 centres in eight countries. The page sets out the treatments the network offers rather than describing an independent local practice, and much of its content is shared with the network's other location pages.
The site lists a wider range of cell preparations here than on some of its other pages: adipose (fat derived) stem cells, bone marrow derived stem cells, umbilical cord derived stem cells, exosomes (small particles released by cells), platelet rich plasma (PRP, prepared from the patient's own blood), growth factors and microRNAs. On cell sourcing the site states that the amniotic cells it uses come from consenting mothers under 35 years of age who donate after a planned caesarean section, that donors are screened, and that DNA factors are removed to reduce the chance of rejection. Those are the company's own claims about its processing and a reader has no way to verify them from the page.
The conditions the page puts forward are unusually broad, covering joint and spine problems, neurological diseases including Parkinson's disease and multiple sclerosis, spinal cord injury, autoimmune disorders, cardiovascular disease and diabetes, with the site stating that most ailments can benefit from regenerative therapy. The page also claims an 85 per cent success rate in improving quality of life. Claims of this breadth and a single headline success figure covering many unrelated diseases are a reason for caution rather than reassurance: stem cell treatment for most of these conditions is still investigational, and the figure is not broken down by condition or independently verified.
No treating clinician is named for Fort Worth. The only clinician named is the network's chief executive, David Greene, MD, PhD, MBA, who the page says presents its webinars. No address, facility description or price is given, so a prospective patient would need to ask who would perform the procedure, which cell product would be used, what it costs in total, and what evidence supports its use for their own diagnosis.
The site lists conditions across several unrelated specialties and states that most ailments can benefit from regenerative therapy, a claim far broader than current evidence supports.
The site says it offers both autologous preparations, taken from the patient's own fat, bone marrow or blood, and allogeneic cells from donated birth tissue.
No clinician who would treat patients in Fort Worth is named; the only named individual is the network's chief executive.
The page contains no description of premises in Fort Worth: no street address, no account of treatment facilities or imaging equipment, and no opening hours. It functions as a marketing page for the network, with enquiries routed to a central telephone number and a free consultation rather than to a named local office. A prospective patient would need to establish by telephone where treatment would be given and by whom.
The page publishes no prices. The network states that stem cell therapy is not covered by insurance and must be paid for out of pocket, and that financing through third party lenders may be available to qualifying patients. Cost is only discussed at a free consultation, so the site gives a reader no basis for comparing price with other clinics.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.